GeneOnline Asia inc
Selected as a startup company by FINDIT Matchmaking in the past two years
Update:2026/11/10
Industries
Main Industry
Media and Entertainment
Main Product/Service
We are a Premier Biotech Media
We are a Premier Biotech Media that offers the most in-depth healthcare and biopharma insights.
We are a Premier Biotech Media that offers the most in-depth healthcare and biopharma insights.
The content above was translated by Ai
Founded Year
2021
Unified Business No.
90516582
Status
Active
Number of Employees
20
Total Paid-in
Capital
5,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Overseas Development
Japan、United States of America
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We are a Premier Biotech Media that offers the most in-depth healthcare and biopharma insights.
Our Mission is to provide the latest global biotech/pharma trends and developments including conducting exclusive KOL interviews, publishing industry news and innovative technology trends, and covering global conferences and events.
Our Mission is to provide the latest global biotech/pharma trends and developments including conducting exclusive KOL interviews, publishing industry news and innovative technology trends, and covering global conferences and events.
The content above was translated by Ai